| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 81, 4418-4421, Copyright © 1996 by Endocrine Society
ARTICLES |
RE Pratley, M Nicolson, C Bogardus and E Ravussin
Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona 85016, USA. Richard Pratley@nih.gov
Leptin, a recently discovered protein produced in adipocytes, may be important in the regulation of body energy stores. In humans, leptin is present in the circulation in direct proportion to the amount of body fat. In rodents, insulin seems to regulate the production of leptin, but there is only limited evidence that this occurs in humans. We, therefore, measured plasma leptin concentrations in 13 insulin- sensitive and 13 insulin-resistant Pima Indians at baseline, at the end of 100 min of physiologic hyperinsulinemia (mean plasma insulin = 563 pmol/L) and after a further 100 min of supraphysiologic hyperinsulinemia (mean plasma insulin = 11,910 pmol/L), during a 2-step hyperinsulinemic-euglycemic glucose clamp. At baseline, plasma leptin concentrations were directly related to percent body fat, determined by hydrodensitometry (r = 0.85, P < 0.0001). After adjusting for percent body fat, there were no differences in fasting plasma leptin concentrations between insulin-sensitive and insulin-resistant subjects. Plasma leptin concentrations did not change in response to insulin in either the insulin-sensitive or insulin-resistant subjects. These results suggest that insulin does not acutely regulate plasma leptin concentrations in humans.
This article has been cited by other articles:
![]() |
A.K. Ludwig, J.M. Weiss, S. Tauchert, T. Dietze, S. Rudolf, K. Diedrich, A. Peters, and K.M. Oltmanns Influence of hypo- and hyperglycaemia on plasma leptin concentrations in healthy women and in women with polycystic ovary syndrome Hum. Reprod., June 1, 2007; 22(6): 1555 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Sonnenberg, G. R. Krakower, R. G. Hoffmann, D. L. Maas, M. M. I. Hennes, and A. H. Kissebah Plasma Leptin Concentrations during Extended Fasting and Graded Glucose Infusions: Relationships with Changes in Glucose, Insulin, and FFA J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4895 - 4900. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Fried, M. R. Ricci, C. D. Russell, and B. Laferrere Regulation of Leptin Production in Humans J. Nutr., December 1, 2000; 130 (12): 3127S - 3131S. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. CLAYCOMBE, B. Z. XUE, R. L. MYNATT, M. B. ZEMEL, and N. MOUSTAID-MOUSSA Regulation of leptin by agouti Physiol Genomics, April 27, 2000; 2(3): 101 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Damjanovic, M. S. Petakov, D. Micic, J. Marinkovic, C. Dieguez, F. F. Casanueva, and V. Popovic Serum Leptin Levels in Patients with Acromegaly before and after Correction of Hypersomatotropism by Trans-Sphenoidal Surgery J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 147 - 154. [Abstract] [Full Text] |
||||
![]() |
Changes in Plasma Leptin during the Treatment of Diabetic Ketoacidosis J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4545 - 4548. [Abstract] [Full Text] |
||||
![]() |
G. Paolisso, M. R. Tagliamonte, M. Galderisi, G. A. Zito, A. Petrocelli, C. Carella, O. de Divitiis, and M. Varricchio Plasma Leptin Level Is Associated With Myocardial Wall Thickness in Hypertensive Insulin-Resistant Men Hypertension, November 1, 1999; 34(5): 1047 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Attia, S. Caprio, T. W. Jones, R. Heptulla, J. Holcombe, D. Silver, R. S. Sherwin, and W. V. Tamborlane Changes in Free Insulin-Like Growth Factor-1 and Leptin Concentrations during Acute Metabolic Decompensation in Insulin Withdrawn Patients with Type 1 Diabetes J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2324 - 2328. [Abstract] [Full Text] |
||||
![]() |
F-X. Pi-Sunyer and B. Laferrère Metabolic Abnormalities and the Role of Leptin in Human Obesity J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 3 - 7. [Full Text] |
||||
![]() |
P. J. Havel, J. Y. Uriu-Hare, T. Liu, K. L. Stanhope, J. S. Stern, C. L. Keen, and B. Ahren Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1998; 274(5): R1482 - R1491. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Donahoo, D. R. Jensen, T. J. Yost, and R. H. Eckel Isoproterenol and Somatostatin Decrease Plasma Leptin in Humans: A Novel Mechanism Regulating Leptin Secretion J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4139 - 4143. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Bray and D. A. York Leptin and Clinical Medicine: A New Piece in the Puzzle of Obesity J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2771 - 2776. [Full Text] [PDF] |
||||
![]() |
G. A. Laughlin, A. J. Morales, and S. S. C. Yen Serum Leptin Levels in Women with Polycystic Ovary Syndrome: The Role of Insulin Resistance/ Hyperinsulinemia J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1692 - 1696. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |